Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio
We wrote about Elevance Health (NYSE: ELV ) in December of last year . Share prices were down approximately 30% after the Q3 results. The company had revised its short-term and long-term growth outlook. With theWe use Cash Flow Returns On Investment based DCF valuation tools provided by our affiliate company, ROCGA Research.With over 20 years of experience in investment analysis, we are actively seeking out undervalued and quality companies.ROCGA Research is an online platform that provides an objective and ...